Skip Navigation


NDT Plus Advance Access originally published online on March 27, 2008
NDT Plus 2008 1(3):192-193; doi:10.1093/ndtplus/sfn022
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/3/192    most recent
sfn022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thachil, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The implications of aspirin resistance in renal failure

Jecko Thachil

Department of Haematology, Royal Liverpool, Liverpool, UK

Correspondence: E-mail: jeckothachil@yahoo.co.uk

The first 10% of the full text of this article appears below.

Sir,

Aspirin resistance is a phenomenon where the expected inhibition of platelet responses is not obtained as evaluated by different biological tests [1]. In addition to non-compliance and other patient-related factors, one of the main reasons for aspirin resistance is its inability to inhibit thromboxane A2 (TXA2) biosynthesis in vivo.

Many studies . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?